Aprepitant/Fosaprepitant Dimeglumine and Emicizumab-kxwh Subcutaneous
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Emicizumab-kxwh Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Emla
- Aprepitant/Fosaprepitant Dimeglumine-Emla Topical
- Aprepitant/Fosaprepitant Dimeglumine-Emo-Cort Scalp Solution Topical application
- Aprepitant/Fosaprepitant Dimeglumine-Emo-Cort Topical application
- Aprepitant/Fosaprepitant Dimeglumine-Emoquette
- Aprepitant/Fosaprepitant Dimeglumine-Empagliflozin
- Emicizumab-kxwh Subcutaneous-Apresazide
- Emicizumab-kxwh Subcutaneous-Apresoline
- Emicizumab-kxwh Subcutaneous-Apresoline Injection
- Emicizumab-kxwh Subcutaneous-Apri
- Emicizumab-kxwh Subcutaneous-Apriso
- Emicizumab-kxwh Subcutaneous-Aprizio Pak